soul semaglutide (Semaglutide cardiOvascular oUtcomes triaL) in individuals with Oral Semaglutide Gets FDA Approval

The Virta Health data provides equally important evidence, though from a different angle

In October 2023, researchers published one of the first comprehensive studies examining the links between severe gastroparesis and Ozempic, as well as similar drugs

Weight loss not cited as sole reason for hair loss The study found that the drugs themselves may not be directly damaging hair follicles, but rather the broad metabolic, hormonal, and immunological effects attributed to GLP-1 receptor agonists that may influence hair follicle growth and cycling. That means it appears that hair loss is not due to the drug itself, but rather the body losing weight too quickly, according to Netchiporouk

The researchers described its potency as roughly 10 million-fold greater than BDNF in the synaptogenesis assay